Literature DB >> 4338124

The appearance of lecithin- 32 P, synthesized from lysolecithin- 32 P, in phagosomes of polymorphonuclear leukocytes.

P Elsbach, P Patriarca, P Pettis, T P Stossel, R J Mason, M Vaughan.   

Abstract

Rabbit polymorphonuclear leukocytes ingesting paraffin oil particles stabilized with albumin, converted more lysolecithin-(32)P (added to the medium as an albumin complex) to cellular lecithin than did control cells. Almost all of the increment in leukocyte lecithin-(32)P is found in association with the isolated phagocytic vacuoles. About half of lecithin-(32)P of granulocytes incubated first with lysolecithin-(32)P and then reincubated with paraffin particles in a nonradioactive medium is transferred from a sedimentable (presumably membrane) fraction to the phagosomes. Isolated phagosomes or granules by themselves are capable of acylating lysolecithin. The main source of lysolecithin-(32)P for synthesis of cellular lecithin-(32)P, however, appears to be extracellular rather than lysolecithin-(32)P within the cytoplasm or the phagocytic vacuole. We interpret our findings therefore as indicating that lecithin-(32)P in the phagosomes derives chiefly from the outer membrane.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4338124      PMCID: PMC292340          DOI: 10.1172/JCI106994

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  7 in total

1.  Increased lecithin synthesis during phagocytosis by normal leukocytes and by leukocytes of a patient with chronic granulomatous disease.

Authors:  P Elsbach; D Zucker-Franklin; C Sansaricq
Journal:  N Engl J Med       Date:  1969-06-12       Impact factor: 91.245

2.  Phospholipid metabolism by phagocytic cells. I. A comparison of conversion of [32P]lysolecithin to lecithin and glycerylphosphorylcholine by homogenates of rabbit polymorphonuclear leukocytes and alveolar macrophages.

Authors:  P Elsbach
Journal:  Biochim Biophys Acta       Date:  1966-12-07

3.  Isolation and properties of phagocytic vesicles. II. Alveolar macrophages.

Authors:  T P Stossel; R J Mason; T D Pollard; M Vaughan
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

4.  Increased synthesis of phospholipid during phagocytosis.

Authors:  P Elsbach; S Levy
Journal:  J Clin Invest       Date:  1968-10       Impact factor: 14.808

5.  Isolation and properties of phagocytic vesicles from polymorphonuclear leukocytes.

Authors:  T P Stossel; T D Pollard; R J Mason; M Vaughan
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

6.  ELECTRON MICROSCOPE STUDIES ON THE DEGRANULATION OF RABBIT PERITONEAL LEUKOCYTES DURING PHAGOCYTOSIS.

Authors:  D ZUCKER-FRANKLIN; J G HIRSCH
Journal:  J Exp Med       Date:  1964-10-01       Impact factor: 14.307

7.  The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes.

Authors:  Z A COHN; J G HIRSCH
Journal:  J Exp Med       Date:  1960-12-01       Impact factor: 14.307

  7 in total
  5 in total

1.  Metabolic basis for asthma and rhinitis: an integrated approach.

Authors:  K P Agrawal; D Mehta; S Gupta; S K Chhabra
Journal:  Lung       Date:  1986       Impact factor: 2.584

2.  Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase.

Authors:  R M Clancy; J Leszczynska-Piziak; S B Abramson
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

3.  Phagosomal membrane lipids of LM fibroblasts.

Authors:  F Schroeder
Journal:  J Membr Biol       Date:  1982       Impact factor: 1.843

4.  Effect of phagocytosis and ionophores on release and metabolism of arachidonic acid from human neutrophils.

Authors:  C E Walsh; L R Dechatelet; M J Thomas; J T O'Flaherty; M Waite
Journal:  Lipids       Date:  1981-02       Impact factor: 1.880

5.  Sequential degranulation of the two types of polymorphonuclear leukocyte granules during phagocytosis of microorganisms.

Authors:  D F Bainton
Journal:  J Cell Biol       Date:  1973-08       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.